Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants

NCT05936541 is registered in ClinicalTrials.gov with Liaquat University of Medical & Health Sciences as lead sponsor.

NCT NCT05936541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05936541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants
Lead sponsor
Liaquat University of Medical & Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2020
Completion date
May 25, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disbiosis